Compounds > methylprednisolone

methylprednisolone and Lymphoma, B-Cell, Marginal Zone

methylprednisolone has been researched along with Lymphoma, B-Cell, Marginal Zone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chaparro, M; Díaz, R; Gisbert, JP; Rodríguez-Grau, Mdel C1
Yoshida, K1
Kokosadze, NV; Logvinenko, OA; Mitrikov, BV; Nikitin, EA; Rodionova, EB; Varlamova, EIu; Vasil'ev, VI1
Feliu, E; Gonzàlez, N; Jové, J; Olivé, A; Ribera, JM; Xicoy, B1
Ghadimi, BM; Hohloch, K; Marx, A; Sauer, C; Schaefer, IM; Ströbel, P; Trümper, L1
Akcali, Z; Kayaselcuk, F; Ozyilkan, O; Sakalli, H1

Other Studies

6 other study(ies) available for methylprednisolone and Lymphoma, B-Cell, Marginal Zone

ArticleYear
[Infliximab in the treatment of refractory gastroduodenal Crohn's disease].
    Gastroenterologia y hepatologia, 2014, Volume: 37, Issue:1

    Topics: Adult; Anti-Bacterial Agents; Antibodies, Monoclonal; Azathioprine; Crohn Disease; Drug Resistance; Drug Substitution; Duodenal Ulcer; Female; Gastritis; Gastroscopy; Helicobacter Infections; Helicobacter pylori; Humans; Immunosuppressive Agents; Infliximab; Lymphoma, B-Cell, Marginal Zone; Mesalamine; Methylprednisolone; Rectovaginal Fistula; Recurrence; Remission Induction; Stomach Neoplasms

2014
Deep-seated mycosis.
    Medical mycology journal, 2014, Volume: 55, Issue:2

    Topics: Aspergillosis; Aspergillus fumigatus; Hepatitis B; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Liver Neoplasms; Lymphoma, B-Cell, Marginal Zone; Male; Methylprednisolone; Middle Aged; Prednisolone; Psoas Abscess; Pulse Therapy, Drug; Tomography, X-Ray Computed

2014
[Combination of rituximab with combined pulse-therapy with high doses of methylprednisolone and cyclophosphamide: effects on immunomorphological and functional disturbances of the salivary glands in a patient with Sjogren's disease and MALT-lymphoma].
    Terapevticheskii arkhiv, 2008, Volume: 80, Issue:5

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Cyclophosphamide; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunologic Factors; Lymphoma, B-Cell, Marginal Zone; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Rituximab; Salivation; Sjogren's Syndrome; Submandibular Gland

2008
Systemic lupus erythematosus in a patient with primary MALT lymphoma of the larynx.
    Ear, nose, & throat journal, 2009, Volume: 88, Issue:8

    Topics: Adult; Female; Glucocorticoids; Humans; Hydroxychloroquine; Laryngeal Neoplasms; Lupus Erythematosus, Systemic; Lymphoma, B-Cell, Marginal Zone; Methylprednisolone; Neoplasms, Radiation-Induced; Treatment Outcome

2009
Massive intrafollicular and arterial hyalinosis of the spleen following rituximab and methylprednisolone therapy in a patient with splenic marginal zone lymphoma.
    Histopathology, 2013, Volume: 62, Issue:4

    Topics: Actins; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Arteries; Biomarkers, Tumor; Drug Therapy, Combination; Humans; Hyalin; Lymphoma, B-Cell, Marginal Zone; Male; Methylprednisolone; Rituximab; Spleen; Splenectomy; Splenic Neoplasms; Treatment Outcome; Ultrasonography

2013
MALTOMA presenting with thrombocytopenia.
    American journal of clinical oncology, 2005, Volume: 28, Issue:3

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Cyclophosphamide; Diarrhea; Doxorubicin; Duodenal Neoplasms; Female; Humans; Immunoglobulins, Intravenous; Lymphoma, B-Cell, Marginal Zone; Methylprednisolone; Prednisone; Remission Induction; Stomach Neoplasms; Thrombocytopenia; Vincristine

2005